NASDAQ:SLP - Simulations Plus Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$19.92 +0.57 (+2.95 %)
(As of 01/15/2019 04:00 PM ET)
Previous Close$19.35
Today's Range$19.36 - $20.43
52-Week Range$14.25 - $23.95
Volume52,947 shs
Average Volume88,289 shs
Market Capitalization$350.24 million
P/E Ratio39.84
Dividend Yield1.20%
Beta-0.55
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a standalone program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for NCA and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher. In addition, it offers MedChem Studio, a software tool for data mining and designing new molecules; KIWI, a cloud-based Web application to organizes, processes, maintains, and communicates the volume of data and results generated by pharmacologists and scientists over the duration of a drug development program; DILIsym, a quantitative systems pharmacology software; NAFLDsym, a simulation program for analyzing nonalcoholic fatty liver disease; and RENAsym for investigating and predicting drug-induced or acute kidney injury. Further, the company provides population modeling and simulation contract research services for the pharmaceutical and biotechnology industries; and clinical-pharmacology-based consulting services in support of regulatory submissions. It sells its pharmaceutical/chemistry software to pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies. The company was founded in 1996 and is headquartered in Lancaster, California.

Receive SLP News and Ratings via Email

Sign-up to receive the latest news and ratings for SLP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Computer integrated systems design
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:SLP
CUSIPN/A
Phone661-723-7723

Debt

Current Ratio3.43
Quick Ratio3.43

Price-To-Earnings

Sales & Book Value

Annual Sales$29.67 million
Price / Sales11.72
Cash Flow$0.6664 per share
Price / Cash Flow29.89
Book Value$1.84 per share
Price / Book10.83

Profitability

Net Income$8.93 million
Net Margins29.05%
Return on Assets17.16%

Miscellaneous

Employees93
Market Cap$350.24 million
OptionableOptionable

Simulations Plus (NASDAQ:SLP) Frequently Asked Questions

What is Simulations Plus' stock symbol?

Simulations Plus trades on the NASDAQ under the ticker symbol "SLP."

How often does Simulations Plus pay dividends? What is the dividend yield for Simulations Plus?

Simulations Plus declared a quarterly dividend on Thursday, January 10th. Stockholders of record on Friday, January 25th will be paid a dividend of $0.06 per share on Friday, February 1st. This represents a $0.24 annualized dividend and a dividend yield of 1.20%. The ex-dividend date is Thursday, January 24th. View Simulations Plus' Dividend History.

How were Simulations Plus' earnings last quarter?

Simulations Plus, Inc. (NASDAQ:SLP) issued its earnings results on Wednesday, January, 9th. The technology company reported $0.09 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.11 by $0.02. The technology company had revenue of $7.54 million for the quarter, compared to analysts' expectations of $7.45 million. Simulations Plus had a net margin of 29.05% and a return on equity of 23.26%. View Simulations Plus' Earnings History.

When is Simulations Plus' next earnings date?

Simulations Plus is scheduled to release their next quarterly earnings announcement on Monday, April 8th 2019. View Earnings Estimates for Simulations Plus.

What guidance has Simulations Plus issued on next quarter's earnings?

Simulations Plus issued an update on its FY 2019 earnings guidance on Wednesday, January, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $32.633-34.117 million, compared to the consensus revenue estimate of $32.5 million.

Has Simulations Plus been receiving favorable news coverage?

Headlines about SLP stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Simulations Plus earned a coverage optimism score of 1.9 on InfoTrie's scale. They also assigned media coverage about the technology company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near term.

Who are some of Simulations Plus' key competitors?

Who are Simulations Plus' key executives?

Simulations Plus' management team includes the folowing people:
  • Mr. Walter S. Woltosz, Co-Founder & Chairman (Age 74)
  • Mr. Shawn M. O'Connor, Chief Exec. Officer (Age 59)
  • Mr. John R. Kneisel, Chief Financial Officer (Age 61)
  • Dr. Thaddeus Henry Grasela Jr., Pharm.D., PharmD, Ph.D., Pres Buffalo Division, Director of Simulations Plus & Director (Age 65)
  • Mr. John Anthony DiBella, Pres of the Lancaster Division (Age 39)

How do I buy shares of Simulations Plus?

Shares of SLP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Simulations Plus' stock price today?

One share of SLP stock can currently be purchased for approximately $19.92.

How big of a company is Simulations Plus?

Simulations Plus has a market capitalization of $350.24 million and generates $29.67 million in revenue each year. The technology company earns $8.93 million in net income (profit) each year or $0.50 on an earnings per share basis. Simulations Plus employs 93 workers across the globe.

What is Simulations Plus' official website?

The official website for Simulations Plus is http://www.simulations-plus.com.

How can I contact Simulations Plus?

Simulations Plus' mailing address is 42505 10TH STREET WEST, LANCASTER CA, 93534. The technology company can be reached via phone at 661-723-7723 or via email at [email protected]


MarketBeat Community Rating for Simulations Plus (NASDAQ SLP)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  172 (Vote Outperform)
Underperform Votes:  208 (Vote Underperform)
Total Votes:  380
MarketBeat's community ratings are surveys of what our community members think about Simulations Plus and other stocks. Vote "Outperform" if you believe SLP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SLP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel